Form 4: Director Christiane Pendarvis Exercises HIMS RSUs

Director Christiane Pendarvis acquired 3,656 shares of Hims & Hers Health, Inc. Class A Common Stock through the vesting of restricted stock units.

Summary

• Director Christiane Pendarvis exercised 3,656 restricted stock units (RSUs) on June 11, 2026.
• Each RSU converted into one share of Class A Common Stock at no additional cost.
• Following the transaction, the director holds a total of 55,430 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, representing standard administrative equity vesting for a company director.

Positives

• The transaction reflects the standard vesting of equity compensation for a board member, aligning director interests with shareholders.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

Not applicable as this is a routine insider transaction filing.

Industry Context

StockSavvy.ai notes that routine RSU vesting for directors is a standard corporate governance practice and does not typically signal a change in strategic direction or market sentiment.

Comparison to Industry Standards

• The transaction follows standard equity compensation structures common among publicly traded technology and healthcare companies.

Stakeholder Impact

• Minimal impact on shareholders as this is a routine equity settlement.

Key Dates

Keywords

Hims & Hers Health, HIMS, Form 4, Insider Trading, Equity Compensation, Director Ownership